About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
193 genotypes with 210 annotations displayed of selected term and subterms
Searched Term: atherosclerotic lesions
Allelic Composition
(Genetic Background)		 Annotated Term Reference
Ay/a
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl) 		atherosclerotic lesions J:177084
Aorls1C57BL/6J/Aorls1DBA/2J
(involves: C57BL/6J * DBA/2J) 		atherosclerotic lesions J:84091
Aorls1DBA/2J/Aorls1DBA/2J
(involves: C57BL/6J * DBA/2J) 		atherosclerotic lesions J:84091
Aorls2C57BL/6J/?
(involves: C57BL/6J * DBA/2J) 		atherosclerotic lesions J:84091
Apobtm1Sgy/Apobtm1Sgy
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) 		increased susceptibility to atherosclerosis J:41510
Apobtm2Sgy/Apobtm2Sgy
Apoetm1Unc/Apoetm1Unc
Lepob/Lepob
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) 		atherosclerotic lesions J:133453
Apobtm2Sgy/Apobtm2Sgy
Ldlrtm1Her/Ldlrtm1Her
Lepob/Lepob
(involves: 129S7/SvEvBrd * C57BL/6) 		atherosclerotic lesions J:133453
Apobtm2Sgy/Apobtm2Sgy
Ldlrtm1Her/Ldlrtm1Her
Tg(Ins-Igf2)1Fbos/?
(involves: 129S7/SvEvBrd * C57BL/6 * SJL) 		atherosclerotic lesions J:141333
Apobec1tm1Ddsn/Apobec1tm1Ddsn
Fggtm1Fjc/Fggtm1Fjc
Ldlrtm1Her/Ldlrtm1Her
(B6.129-Fggtm1Fjc Apobec1tm1Ddsn Ldlrtm1Her) 		atherosclerotic lesions J:132734
Apobec1tm1Ddsn/Apobec1tm1Ddsn
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		atherosclerotic lesions J:49125
Apobec1tm1Ddsn/Apobec1tm1Ddsn
Ldlrtm1Her/Ldlrtm1Her
(B6.129-Apobec1tm1Ddsn Ldlrtm1Her) 		atherosclerotic lesions J:132734
Apoeshl/Apoeshl
(KOR-Apoeshl) 		increased susceptibility to atherosclerosis J:75488
Apoeshl/Apoeshl
(C3.KOR-Apoeshl) 		increased susceptibility to atherosclerosis J:75488
Apoeshl/Apoeshl
(C.KOR-Apoeshl) 		increased susceptibility to atherosclerosis J:75488
Apoeshl/Apoeshl
(B6.KOR-Apoeshl) 		increased susceptibility to atherosclerosis J:75488
Apoeshl/Apoeshl
(involves: C3H/He * KOR) 		atherosclerotic lesions J:54051
Apoeshl/Apoeshl
(involves: BALB/c * KOR) 		atherosclerotic lesions J:54051
Apoeshl/Apoeshl
(involves: C57BL/6 * KOR) 		atherosclerotic lesions J:54051
ApoeTg(rtTA)1Gaga/ApoeTg(rtTA)1Gaga
(involves: 129S1/Sv * C57BL/6J) 		increased susceptibility to atherosclerosis J:136987
ApoeTg(rtTA)1Gaga/ApoeTg(rtTA)1Gaga
Igs7tm1(tetO-Apoe)Gaga/0
(involves: 129S1/Sv * C57BL/6J) 		increased susceptibility to atherosclerosis J:136987
Apoetm1(APOE*2)Mae/Apoetm1(APOE*2)Mae
(involves: 129P2/OlaHsd * C57BL/6) 		atherosclerotic lesions J:48565
increased susceptibility to atherosclerosis J:48565
Apoetm1Bres/Apoetm1Bres
(either: (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * C57BL/6J)) 		increased susceptibility to atherosclerosis J:2809
Apoetm1Bres/Apoetm1Bres
(involves: 129P2/OlaHsd * C57BL/6 * NIH Black Swiss) 		atherosclerotic lesions J:42927
Apoetm1Bres/Apoetm1Bres
(involves: 129P2/OlaHsd * C57BL/6) 		atherosclerotic lesions J:29950
increased susceptibility to atherosclerosis J:43846
Apoetm1Bres/Apoetm1Bres
(B6.129P2-Apoetm1Bres) 		atherosclerotic lesions J:68574
Apoetm1Bres/Apoetm1Bres
Bcl2tm1Irt/Bcl2tm1Irt
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6) 		atherosclerotic lesions J:144243
Apoetm1Bres/Apoetm1Bres
Cd59atm1Bpm/Cd59atm1Bpm
(involves: 129 * 129P2/OlaHsd) 		increased susceptibility to atherosclerosis J:158457
Apoetm1Bres/Apoetm1Bres
Esr1tm1Ksk/Esr1tm1Ksk
(B6.129P2-Apoetm1Bres Esr1tm1Ksk) 		atherosclerotic lesions J:68574
increased susceptibility to atherosclerosis J:68574
Apoetm1Bres/Apoetm1Bres
Mapk8tm1Flv/Mapk8tm1Flv
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6) 		atherosclerotic lesions J:94044
Apoetm1Bres/Apoetm1Bres
Plgtm1Jld/Plgtm1Jld
(involves: 129P2/OlaHsd * C57BL/6 * NIH Black Swiss) 		atherosclerotic lesions J:42927
Apoetm1Khw/Apoetm1Khw
Tg(Mx1-cre)29-4Her/0
(B6.Cg-Apoetm1Khw Tg(Mx1-cre)29-4Her) 		increased susceptibility to atherosclerosis J:196923
Apoetm1Lmh/Apoe+
(involves: 129S7/SvEvBrd * C57BL/6) 		atherosclerotic lesions J:22347
Apoetm1Lmh/Apoetm1Lmh
Ldlrtm1Her/Ldlrtm1Her
Lrp1tm2Her/Lrp1tm2Her
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd) 		atherosclerotic lesions J:129557
increased susceptibility to atherosclerosis J:129557
Apoetm1Lmh/Apoetm1Lmh
Ldlrtm1Her/Ldlrtm1Her
Lrp1tm2Her/Lrp1tm2Her
Tg(Mx1-cre)29-4Her/0
(involves: 129S7/SvEvBrd * C57BL/6J * SJL) 		increased susceptibility to atherosclerosis J:90547
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J) 		atherosclerotic lesions J:97385, J:60364, J:91058, J:101576, J:108154, J:73202, J:142083, J:105736
increased susceptibility to atherosclerosis J:43846, J:101576
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6) 		atherosclerotic lesions J:40136, J:41510, J:16573, J:80689
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd) 		increased susceptibility to atherosclerosis J:107390
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc) 		atherosclerotic lesions J:61287
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		atherosclerotic lesions J:66419
Apoetm1Unc/Apoetm1Unc
(B6.Cg-Apoetm1Unc Faslpr) 		increased susceptibility to atherosclerosis J:133606
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		atherosclerotic lesions J:130658
Apoetm1Unc/Apoetm1Unc
Ath29C57BL/6J/?
(involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6J) 		increased susceptibility to atherosclerosis J:127711
Apoetm1Unc/Apoetm1Unc
Ath29C57BL/6J/Ath29C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		atherosclerotic lesions J:140288
Apoetm1Unc/Apoetm1Unc
Ath30C57BL/6J/Ath30C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		atherosclerotic lesions J:140288
Apoetm1Unc/Apoetm1Unc
Ath31C57BL/6J/Ath31C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		atherosclerotic lesions J:140288
Apoetm1Unc/Apoetm1Unc
Ath32C57BL/6J/Ath32C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		atherosclerotic lesions J:140288
Apoetm1Unc/Apoetm1Unc
Ath33C3H/HeJ/Ath33C3H/HeJ
(involves: C3H/HeJ * C57BL/6J) 		atherosclerotic lesions J:140288
Apoetm1Unc/Apoetm1Unc
Athsq3C3H/HeJ/Athsq3C3H/HeJ
(involves: C3H/HeJ * C57BL/6J) 		atherosclerotic lesions J:140288
Apoetm1Unc/Apoetm1Unc
Athsq3C57BL/6J/Athsq3C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		atherosclerotic lesions J:140288
Apoetm1Unc/Apoetm1Unc
Cath1C3H/HeJ/Cath1C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		increased susceptibility to atherosclerosis J:129301
Apoetm1Unc/Apoetm1Unc
Cath1C57BL/6J/Cath1C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		increased susceptibility to atherosclerosis J:129301
Apoetm1Unc/Apoetm1Unc
Cbstm1Unc/Cbstm1Unc
Tg(Mt1-CBS)25Waku/0
(involves: 129P2/OlaHsd * C3H * C57BL/6) 		increased susceptibility to atherosclerosis J:168131
Apoetm1Unc/Apoetm1Unc
Ccr1tm1Gao/Ccr1tm1Gao
(involves: 129P2/OlaHsd * 129S4/SvJae) 		atherosclerotic lesions J:128063
Apoetm1Unc/Apoetm1Unc
Ccr5tm1Blck/Ccr5tm1Blck
(involves: 129P2/OlaHsd * C57BL/6) 		atherosclerotic lesions J:128063
Apoetm1Unc/Apoetm1Unc
Ccr5tm1Kuz/Ccr5tm1Kuz
(involves: 129P2/OlaHsd * C57BL/6) 		atherosclerotic lesions J:128063
Apoetm1Unc/Apoetm1Unc
Crptm1Hjf/Crptm1Hjf
(B6.Cg-Crptm1Hjf Apoetm1Unc) 		increased susceptibility to atherosclerosis J:170409
Apoetm1Unc/Apoetm1Unc
Cst3tm1Karl/Cst3tm1Karl
(involves: 129S/SvEv * C57BL/6) 		atherosclerotic lesions J:106879
Apoetm1Unc/Apoetm1Unc
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) 		atherosclerotic lesions J:184647
Apoetm1Unc/Apoetm1Unc
Faslpr/Faslpr
(MRL.Cg-Apoetm1Unc Faslpr) 		increased susceptibility to atherosclerosis J:133606
Apoetm1Unc/Apoetm1Unc
Faslpr/Faslpr
(B6.Cg-Apoetm1Unc Faslpr) 		atherosclerotic lesions J:121671
Apoetm1Unc/Apoetm1Unc
Faslgld/Faslgld
(B6.Cg-Faslgld Apoetm1Unc) 		atherosclerotic lesions J:200141, J:91058
increased susceptibility to atherosclerosis J:91058
Apoetm1Unc/Apoetm1Unc
Fut4tm1Jbl/Fut4tm1Jbl
Fut7tm1Jbl/Fut7tm1Jbl
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		atherosclerotic lesions J:102212
Apoetm1Unc/Apoetm1Unc
Gja5tm1Mchn/Gja5tm1Mchn
Tg(TIE2-lacZ)182Sato/0
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		increased susceptibility to atherosclerosis J:162224
Apoetm1Unc/Apoetm1Unc
Glg1Gt(RST092)Byg/Glg1+
(B6J.129P2-Apoetm1Unc Glg1Gt(RST092)Byg) 		atherosclerotic lesions J:226586
Apoetm1Unc/Apoetm1Unc
Hptm1Alev/Hptm1Alev
(involves: 129) 		atherosclerotic lesions J:134942
Apoetm1Unc/Apoetm1Unc
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to atherosclerosis J:105858
Apoetm1Unc/Apoetm1Unc
Itgb3tm1Hyn/Itgb3tm1Hyn
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		atherosclerotic lesions J:83615
Apoetm1Unc/Apoetm1Unc
Klf15tm1Jain/Klf15tm1Jain
(involves: 129P2/OlaHsd * 129X1/SvJ) 		increased susceptibility to atherosclerosis J:203920
Apoetm1Unc/Apoetm1Unc
Klf15tm2Jain/Klf15tm2Jain
Tg(Tagln-cre)1Jjl/0
(involves: 129P2/OlaHsd * FVB/N) 		increased susceptibility to atherosclerosis J:203920
Apoetm1Unc/Apoetm1Unc
Ldlrtm1Her/Ldlrtm1Her
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J) 		atherosclerotic lesions J:95598
Apoetm1Unc/Apoetm1Unc
Lipgtm1Tq/Lipgtm1Tq
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J) 		atherosclerotic lesions J:93987
Apoetm1Unc/Apoetm1Unc
Msr1tm1Csk/Msr1tm1Csk
(either: (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J * ICR) or (involves: 129P2/OlaHsd * 129X1/SvJ * 129/Sv * ICR)) 		atherosclerotic lesions J:39079
Apoetm1Unc/Apoetm1Unc
Nceh1tm1Ishi/Nceh1tm1Ishi
(B6.129-Nceh1tm1Ishi Apoetm1Unc) 		increased susceptibility to atherosclerosis J:152385
Apoetm1Unc/Apoetm1Unc
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) 		atherosclerotic lesions J:64566
Apoetm1Unc/Apoetm1Unc
Nos3tm1Plh/Nos3tm1Plh
(B6.129-Nos3tm1Plh Apoetm1Unc) 		increased susceptibility to atherosclerosis J:103306
Apoetm1Unc/Apoetm1Unc
Nos3tm1Unc/Nos3tm1Unc
(B6.129P2-Nos3tm1Unc Apoetm1Unc) 		atherosclerotic lesions J:60670
increased susceptibility to atherosclerosis J:60670
Apoetm1Unc/Apoetm1Unc
Pecam1Gt(OST16303)Lex/Pecam1Gt(OST16303)Lex
(B6.129-Apoetm1Unc Pecam1Gt(OST16303)Lex) 		atherosclerotic lesions J:142083
Apoetm1Unc/Apoetm1Unc
Pik3cgtm1Dwu/Pik3cgtm1Dwu
(B6.Cg-Apoetm1Unc Pik3cgtm1Dwu) 		atherosclerotic lesions J:121582
Apoetm1Unc/Apoetm1Unc
Pla2g15tm1Ytan/Pla2g15tm1Ytan
(involves: 129S/SvEv * B6.129P2-Apoetm1Unc/J) 		atherosclerotic lesions J:97471
Apoetm1Unc/Apoetm1Unc
Pon1tm1Lus/Pon1tm1Lus
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J) 		atherosclerotic lesions J:82696
Apoetm1Unc/Apoetm1Unc
Scarb1tm1Kri/Scarb1tm1Kri
(involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) 		atherosclerotic lesions J:201999
Apoetm1Unc/Apoetm1Unc
Serpind1tm1Moto/Serpind1+
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		atherosclerotic lesions J:122173
Apoetm1Unc/Apoetm1Unc
Serpine1tm1Mlg/Serpine1tm1Mlg
(B6.129-Serpine1tm1Mlg Apoetm1Unc) 		atherosclerotic lesions J:61287
Apoetm1Unc/Apoetm1Unc
Soat1tm1Far/Soat1tm1Far
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J) 		atherosclerotic lesions J:61147
Apoetm1Unc/Apoetm1Unc
Spp1tm1Blh/Spp1+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6J) 		atherosclerotic lesions J:86531
Apoetm1Unc/Apoetm1Unc
Sprr3tm1.1Ppy/Sprr3tm1.1Ppy
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J * SJL) 		increased susceptibility to atherosclerosis J:230470
Apoetm1Unc/Apoetm1Unc
Tg(APOC1)1Bres/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J) 		atherosclerotic lesions J:80689
Apoetm1Unc/Apoetm1Unc
Tg(CMV-Serpine1)1Dgi/0
(B6.Cg-Apoetm1Unc Tg(CMV-Serpine1)1Dgi) 		atherosclerotic lesions J:61287
Apoetm1Unc/Apoetm1Unc
Tg(MSR1-Plau)1Ddi/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		increased susceptibility to atherosclerosis J:102208
Apoetm1Unc/Apoetm1Unc
Tnfrsf11btm1Eac/Tnfrsf11btm1Eac
(involves: 129S4/SvJaeSor * C57BL/6) 		atherosclerotic lesions J:128053
Apoetm1Unc/Apoetm1Unc
Tnfsf4Ath1-C57BL/6J/Tnfsf4Ath1-C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		atherosclerotic lesions J:140288
Apoetm1Unc/Apoetm1Unc
Ttpatm1Far/Ttpa+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		atherosclerotic lesions J:66419
Apoetm1Unc/Apoetm1Unc
Ttpatm1Far/Ttpatm1Far
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		atherosclerotic lesions J:66419
Apoetm2(APOE*3)Mae/Apoetm2(APOE*3)Mae
(involves: 129P2/OlaHsd * C57BL/6J) 		atherosclerotic lesions J:48565
increased susceptibility to atherosclerosis J:41705
Apoetm3(APOE*4)Mae/Apoetm3(APOE*4)Mae
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to atherosclerosis J:74417
ArtlesC57BL/6J/?
(involves: C57BL/6J * CAST/Ei) 		increased susceptibility to atherosclerosis J:70961
Ascla1FVB/N/Ascla1FVB/N
(involves: C57BL/6J * FVB/N) 		increased susceptibility to atherosclerosis J:104621
Ascla2FVB/N/Ascla2FVB/N
(involves: C57BL/6J * FVB/N) 		increased susceptibility to atherosclerosis J:104621
Ascla3C57BL/6J/Ascla3C57BL/6J
(involves: C57BL/6J * FVB/N) 		increased susceptibility to atherosclerosis J:104621
Ascla4C57BL/6J/Ascla4C57BL/6J
(involves: C57BL/6J * FVB/N) 		increased susceptibility to atherosclerosis J:104621
Ascla4C57BL/6J/Ascla4FVB/N
(involves: C57BL/6J * FVB/N) 		increased susceptibility to atherosclerosis J:104621
Ascla5C57BL/6J/Ascla5C57BL/6J
(involves: C57BL/6J * FVB/N) 		increased susceptibility to atherosclerosis J:104621
Ascla6C57BL/6J/Ascla6C57BL/6J
(involves: C57BL/6J * FVB/N) 		increased susceptibility to atherosclerosis J:104621
Ath6C57BLKS/J/Ath6C57BLKS/J
(B6.BKS-Ath6) 		atherosclerotic lesions J:56090
Ath8SM/J/Ath8SM/J
(involves: NZB/BlNJ * SM/J) 		atherosclerotic lesions J:94346
increased susceptibility to atherosclerosis J:94346
Ath18129S1/SvImJ/Ath18129S1/SvImJ
Ath19C57BL/6J/Ath19C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J) 		increased susceptibility to atherosclerosis J:88486
Ath18C57BL/6J/Ath18C57BL/6J
Ath19129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J) 		increased susceptibility to atherosclerosis J:88486
Ath20129S1/SvImJ/Ath20129S1/SvImJ
Ath21C57BL/6J/Ath21C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J) 		increased susceptibility to atherosclerosis J:88486
Ath20129S1/SvImJ/Ath20C57BL/6J
Ath21C57BL/6J/Ath21C57BL/6J
(involves: 129S1/SvImJ * C57BL/6J) 		increased susceptibility to atherosclerosis J:88486
Ath20C57BL/6J/Ath20C57BL/6J
Ath21129S1/SvImJ/?
(involves: 129S1/SvImJ * C57BL/6J) 		increased susceptibility to atherosclerosis J:88486
Ath22AKR/J/Ath22DBA/2J
(involves: AKR/J * DBA/2J) 		increased susceptibility to atherosclerosis J:106112
Ath22DBA/2J/Ath22DBA/2J
(involves: AKR/J * DBA/2J) 		increased susceptibility to atherosclerosis J:106112
Ath23AKR/J/Ath23AKR/J
(involves: AKR/J * DBA/2J) 		increased susceptibility to atherosclerosis J:106112
Ath23AKR/J/Ath23DBA/2J
(involves: AKR/J * DBA/2J) 		increased susceptibility to atherosclerosis J:106112
Ath24AKR/J/Ath24DBA/2J
(involves: AKR/J * DBA/2J) 		increased susceptibility to atherosclerosis J:106112
Ath24DBA/2J/Ath24DBA/2J
(involves: AKR/J * DBA/2J) 		increased susceptibility to atherosclerosis J:106112
Ath25AKR/J/Ath25DBA/2J
(involves: AKR/J * DBA/2J) 		increased susceptibility to atherosclerosis J:106112
Ath26AKR/J/Ath26AKR/J
(involves: AKR/J * DBA/2J) 		increased susceptibility to atherosclerosis J:106112
Ath26AKR/J/Ath26DBA/2J
(involves: AKR/J * DBA/2J) 		increased susceptibility to atherosclerosis J:106112
Ath27AKR/J/Ath27DBA/2J
(involves: AKR/J * DBA/2J) 		increased susceptibility to atherosclerosis J:106112
Ath28AKR/J/Ath28DBA/2J
(involves: AKR/J * DBA/2J) 		increased susceptibility to atherosclerosis J:106112
Ath28DBA/2J/Ath28DBA/2J
(involves: AKR/J * DBA/2J) 		increased susceptibility to atherosclerosis J:106112
Ath29C3H/HeJ/Ath29C3H/HeJ
(involves: C3H/HeJ * C57BL/6J) 		atherosclerotic lesions J:106521
Ath29C3H/HeJ/Ath29C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		atherosclerotic lesions J:106521
Ath29C57BL/6J/Ath29C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		atherosclerotic lesions J:106521
Athla1C57BL/6J/Athla1C57BL/6J
(involves: B6.129S7-Ldlrtm1Her/J * PERA/EiJ) 		atherosclerotic lesions J:94548
Athsq1MOLF/Ei/Athsq1C57BL/6J
(involves: 129S7/SvEvBrd * C57BL/6J * MOLF/Ei) 		increased susceptibility to atherosclerosis J:70259
Athsq1MOLF/Ei/Athsq1MOLF/Ei
(involves: 129S7/SvEvBrd * C57BL/6J * MOLF/Ei) 		increased susceptibility to atherosclerosis J:70259
Athsq2C57BL/6J/Athsq2C57BL/6J
(involves: 129S7/SvEvBrd * C57BL/6J * MOLF/Ei) 		increased susceptibility to atherosclerosis J:70259
Cd1d1tm1Luc/Cd1d1tm1Luc
Ldlrtm1Her/Ldlrtm1Her
(B6.129S-Cd1d1tm1Luc Ldlrtm1Her) 		atherosclerotic lesions J:110061
increased susceptibility to atherosclerosis J:110061
Crptm1Hjf/Crptm1Hjf
Ldlrtm1Her/Ldlrtm1Her
(B6.Cg-Crptm1Hjf Ldlrtm1Her) 		atherosclerotic lesions J:170409
Cxcl1tm1Wabo/Cxcl1tm1Wabo
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6) 		atherosclerotic lesions J:107325
Ddr1tm1Wfv/Ddr1tm1Wfv
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ) 		atherosclerotic lesions J:149015
Del(9Apoa1-Apoa4)1Hmez/Del(9Apoa1-Apoa4)1Hmez
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to atherosclerosis J:109005
Del(11Cxcl16-Zmynd15)1Ifc/Del(11Cxcl16-Zmynd15)1Ifc
Ldlrtm1Her/Ldlrtm1Her
(B6.129S-Ldlrtm1Her Del(11Cxcl16-Zmynd15)1Ifc) 		atherosclerotic lesions J:123851
Esr1tm1.1Mma/Esr1tm1.1Mma
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S2/SvPas * 129S7/SvEvBrd) 		increased susceptibility to atherosclerosis J:144952
Esr1tm1Arnal/Esr1tm1Arnal
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd) 		increased susceptibility to atherosclerosis J:144952
Gpr132tm1Witt/Gpr132tm1Witt
Ldlrtm1Her/Ldlrtm1Her
(B6.129-Ldlrtm1Her Gpr132tm1Witt) 		atherosclerotic lesions J:100498
Hps1ep/Hps1ep
(B6.C3Fe-Hps1ep/J) 		increased susceptibility to atherosclerosis J:29748
Hyplip2MRL/MpJ/Hyplip2MRL/MpJ
(involves: BALB/cJ * MRL/MpJ) 		atherosclerotic lesions J:92871
Ifngtm1Ts/Ifngtm1Ts
Ldlrtm1Her/Ldlrtm1Her
(B6.129S7-Ldlrtm1Her Ifngtm1Ts) 		atherosclerotic lesions J:103072
Ins2Akita/Ins2Akita
Ldlrtm1Her/Ldlrtm1Her
(B6.Cg-Ins2Akita Ldlrtm1Her) 		increased susceptibility to atherosclerosis J:174983
Itgb3tm1Hyn/Itgb3tm1Hyn
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6) 		atherosclerotic lesions J:83615
Klf15tm1Jain/Klf15tm1Jain
(involves: 129X1/SvJ) 		increased susceptibility to atherosclerosis J:203920
LdlrHlb301/Ldlr+
(C57BL/6J-LdlrHlb301/J) 		increased susceptibility to atherosclerosis J:82961
LdlrHlb301/LdlrHlb301
(C57BL/6J-LdlrHlb301/J) 		increased susceptibility to atherosclerosis J:82961
Ldlrtm1Her/Ldlr+
Tg(H2-K-AKR1B1)1Tj/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2) 		increased susceptibility to atherosclerosis J:100916
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd) 		atherosclerotic lesions J:228420
increased susceptibility to atherosclerosis J:228420
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		atherosclerotic lesions J:96110
Ldlrtm1Her/Ldlrtm1Her
(B6.129S7-Ldlrtm1Her) 		atherosclerotic lesions J:61287, J:110061
increased susceptibility to atherosclerosis J:100916, J:130794, J:135078, J:110061
Ldlrtm1Her/Ldlrtm1Her
(B6.129S7-Ldlrtm1Her/J) 		atherosclerotic lesions J:103072
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6J) 		atherosclerotic lesions J:29950
increased susceptibility to atherosclerosis J:29950
Ldlrtm1Her/Ldlrtm1Her
Lepob/Lepob
(B6.Cg-Lepob Ldlrtm1Her) 		atherosclerotic lesions J:72027
Ldlrtm1Her/Ldlrtm1Her
Lipetm1Ishi/Lipetm1Ishi
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased susceptibility to atherosclerosis J:152385
Ldlrtm1Her/Ldlrtm1Her
Lipetm1Ishi/Lipetm1Ishi
Nceh1tm1Ishi/Nceh1tm1Ishi
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased susceptibility to atherosclerosis J:152385
Ldlrtm1Her/Ldlrtm1Her
Lrp1tm2Her/Lrp1tm2Her
Tg(Tagln-cre)1Her/0
(involves: 129S7/SvEvBrd * C57BL/6J * SJL) 		atherosclerotic lesions J:82871
increased susceptibility to atherosclerosis J:82871
Ldlrtm1Her/Ldlrtm1Her
Nceh1tm1Ishi/Nceh1tm1Ishi
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased susceptibility to atherosclerosis J:152385
Ldlrtm1Her/Ldlrtm1Her
Nr1h3tm1.1Djm/Nr1h3tm1.1Djm
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * DBA) 		increased susceptibility to atherosclerosis J:184536
Ldlrtm1Her/Ldlrtm1Her
Pfn1tm1Wit/Pfn1+
(B6.129S-Ldlrtm1Her Pfn1tm1Wit) 		atherosclerotic lesions J:140294
Ldlrtm1Her/Ldlrtm1Her
Scarb1tm1Dhu/Scarb1tm1Dhu
(involves: 129S4/SvJae * BALB/c * C57BL/6J) 		atherosclerotic lesions J:62371
Ldlrtm1Her/Ldlrtm1Her
Serpine1tm1Mlg/Serpine1tm1Mlg
(B6.129S-Serpine1tm1Mlg Ldlrtm1Her) 		atherosclerotic lesions J:61287
Ldlrtm1Her/Ldlrtm1Her
Soat1tm1Far/Soat1tm1Far
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J) 		atherosclerotic lesions J:61147
Ldlrtm1Her/Ldlrtm1Her
Tg(APOC3)3707Bres/?
(involves: 129S7/SvEvBrd * C57BL/6J * CBA/J) 		atherosclerotic lesions J:37861
Ldlrtm1Her/Ldlrtm1Her
Tg(CMV-Serpine1)1Dgi/0
(B6.Cg-Ldlrtm1Her Tg(CMV-Serpine1)1Dgi) 		atherosclerotic lesions J:61287
Ldlrtm1Her/Ldlrtm1Her
Tg(H2-K-AKR1B1)1Tj/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2) 		increased susceptibility to atherosclerosis J:100916
Ldlrtm1Her/Ldlrtm1Her
Tlr2tm1Kir/Tlr2tm1Kir
(B6.129-Tlr2tm1Kir Ldlrtm1Her) 		atherosclerotic lesions J:131783, J:102502
Lmnatm1Bliu/Lmnatm1Bliu
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL) 		atherosclerotic lesions J:287256
Lpoem1Zlu/Lpoem1Zlu
(involves: C57BL/6 * SJL) 		atherosclerotic lesions J:307289
Mpotm1Lus/Mpotm1Lus
(involves: 129X1/SvJ * C57BL/6J) 		atherosclerotic lesions J:67586
Mpotm1Lus/Mpotm1Lus
(involves: 129X1/SvJ) 		atherosclerotic lesions J:112270
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd * C57BL/6) 		atherosclerotic lesions J:97522
Pon1tm1Lus/Pon1tm1Lus
(involves: 129X1/SvJ * C57BL/6J) 		increased susceptibility to atherosclerosis J:63392
Pon2Gt(XE661)Byg/Pon2Gt(XE661)Byg
(B6.129P2-Pon2Gt(XE661)Byg) 		increased susceptibility to atherosclerosis J:116935
Pon3tm1Dmsh/Pon3tm1Dmsh
(B6J.129X1-Pon3tm1Dmsh) 		increased susceptibility to atherosclerosis J:234615
Rorasg/Rorasg
(involves: C57BL/6) 		atherosclerotic lesions J:52105
increased susceptibility to atherosclerosis J:52105
Scarb1tm1.1Thh/Scarb1tm1.1Thh
(B6.129X1-Scarb1tm1.1Thh) 		increased susceptibility to atherosclerosis J:114663
Scarb1tm1Thh/Scarb1tm1Thh
(B6.129X1-Scarb1tm1Thh) 		increased susceptibility to atherosclerosis J:114663
Scarb1tm1Thh/Scarb1tm1Thh
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Scarb1tm1Thh Speer6-ps1Tg(Alb-cre)21Mgn) 		increased susceptibility to atherosclerosis J:114663
Shc1tm1Pgp/Shc1tm1Pgp
(involves: 129) 		atherosclerotic lesions J:81977
Tg(Alb-MYLIP*)1Pton/?
(involves: C57BL/6J) 		atherosclerotic lesions J:228420
increased susceptibility to atherosclerosis J:228420
Tg(AlbLCAT)1Jdm/0
(involves: FVB/N) 		increased susceptibility to atherosclerosis J:128254
Tg(AlbLCAT)1Jdm/0
Tg(APOA1)1Rub/0
(involves: C57BL/6 * FVB/N) 		increased susceptibility to atherosclerosis J:128254
Tg(Apoa2)1Lus/?
(involves: C57BL/6J * DBA/2) 		atherosclerotic lesions J:127063
Tg(APOE_i3*,APOC1)2Lmh/?
(B6.Cg-Tg(APOE*3,APOC1)2Lmh) 		atherosclerotic lesions J:101995
Tg(APOE_i3*,APOC1)2Lmh/?
(involves: C57BL/6J * CBA) 		atherosclerotic lesions J:228420
increased susceptibility to atherosclerosis J:228420
Tg(CETP)UCTP20Pnu/0
(C57BL/6-Tg(CETP)UCTP20Pnu) 		increased susceptibility to atherosclerosis J:118358
Tg(Fabp4-Aebp1)1Hsro/?
(involves: FVB) 		atherosclerotic lesions J:125334
Tg(Ins2-Nos2)40Okam/0
Tg(Kdr-AGER)102Hyam/0
(involves: C57BL/6J * CBA/J * CD-1 * DBA/2) 		atherosclerotic lesions J:70495
Tg(Mt1-Tnfsf4)1Pgn/?
(C57BL/6J-Tg(Mt1-Tnfsf4)1Pgn) 		increased susceptibility to atherosclerosis J:97460
Tg(Mt1-Tnfsf4)2Pgn/?
(C57BL/6J-Tg(Mt1-Tnfsf4)2Pgn) 		increased susceptibility to atherosclerosis J:97460
Tlr4Lps-d/Tlr4Lps-d
(B6.C3-Tlr4Lps-d) 		atherosclerotic lesions J:101995
Tnfsf4Ath1-C57BL/6J/?
(involves: C3H/HeJ * C57BL/6J) 		increased susceptibility to atherosclerosis J:8735
Tnfsf4Ath1-C57BL/6J/Tnfsf4Ath1-C57BL/6J
Ath2C57BL/6J/Ath2C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		increased susceptibility to atherosclerosis J:9832
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory